Thomas D. Rogers Member

• Medical Devices
• Medical Malpractice and Pharmacy Liability
• Pharmaceutical Drugs

• 1980, South Carolina
• 1982, U.S. District Court, District of South Carolina

• University of South Carolina, J.D., magna cum laude, 1980
• University of Virginia, B.A., with distinction, 1975

• Charleston County Bar Association
• Martindale-Hubbell Rated: AV
• South Carolina Association for Justice
• South Carolina Bar
• The American Association for Justice
• Best Lawyers in America, 2018 (Medical Malpractice & Personal Injury)

Zyprexa Multidistrict Litigation
The anti-depressant drug Zyprexa causes some patients to develop diabetes or worsen their pre-existing diabetes. As a result of the litigation, Eli Lilly agreed to pay $1.2 billion to 28,500 individuals. Rogers served on the Plaintiff’s Steering Committee of the MDL.

Bausch & Lomb Contact Lens Solution Products Liability Litigation
The contact lens solution ReNu with MoistureLoc was pulled from the market after it was found to cause serious eye injuries. RPWB was lead counsel in the multidistrict litigation to compensate people who sustained injuries from using the product. Rogers served on the Plaintiff’s Steering Committee.

Ortho Evra
The birth control patch provided inconsistent dosages and led to an increased risk of blood clots. Rogers served on the Plaintiff’s Steering Committee and worked to establish causation between the drug and the side effects it caused.

L-Tryptophan
When thousands of people began developing the debilitating disease eosinophilia-myalgia syndrome (EMS), the investigation determined that the cause was L-tryptophan manufactured by the Japanese company Showa Denko K.K. The cases were consolidated in South Carolina, and Rogers served as a member of the Plaintiff’s Steering Committee and was Plaintiff’s Liaison Counsel.

Breast Implant Litigation
Rogers played an important role in litigation against several manufacturers of breast implants for selling defective products, including the MDL against Dow Corning that resulted in a $3.2 billion settlement for 400,000 women.